Cilostazol/ginkgo-biloba

西洛他唑/银杏叶提取物

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCilostazol/ginkgo-biloba

Drug Alias NameCilostazol/ginkgo-biloba immediate releaseCilostazol/ginkgo-biloba controlled releaseRenexinSID-142

ClassificationSmall molecules

Mechanisms of ActionPhosphodiesterase 3 inhibitors

TargetsPhosphodiesterase 3

Therapy Area/IndicationsCognitionDiabetes Mellitus, Type 2Thromboangiitis Obliterans +[7]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsYes Cilostazol

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesSk Chemicals

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCognitionDiabetes Mellitus, Type 2Thromboangiitis Obliterans +[6]

Inactive IndicationsPeripheral Arterial Disease

ATC CodeV03AM